» Articles » PMID: 2538645

Response of the Human T-cell Leukemia Virus Type 1 Long Terminal Repeat to Cyclic AMP

Overview
Journal J Virol
Date 1989 Apr 1
PMID 2538645
Citations 34
Authors
Affiliations
Soon will be listed here.
Abstract

The sequences that control transcriptional initiation of the provirus of the human T-cell leukemia virus type 1 (HTLV-1) are shown to be responsive to intracellular levels of cyclic AMP. A heptanucleotide sequence present within the 21-nucleotide repeat sequence that is similar to the cyclic AMP-responsive consensus (CRE) sequence was required for cyclic AMP-mediated increase in gene expression. Although the CRE-like sequences were contained within sequences that were responsive to the virally encoded trans-activator (tax), the evidence presented indicates that the mechanisms of promoter induction by the tax product and cyclic AMP are independent. The implication of cyclic AMP stimulation of HTLV-1 provirus gene expression for long-term persistence of infected T cells and for virus-induced transformation is discussed.

Citing Articles

A Novel Tax-Responsive Reporter T-Cell Line to Analyze Infection of HTLV-1.

Heym S, Krebs P, Ott K, Donhauser N, Kemeter L, Simon F Pathogens. 2024; 13(11).

PMID: 39599568 PMC: 11597676. DOI: 10.3390/pathogens13111015.


Regulation of Expression and Latency in BLV and HTLV.

Pluta A, Jaworski J, Douville R Viruses. 2020; 12(10).

PMID: 32992917 PMC: 7601775. DOI: 10.3390/v12101079.


Elevated cyclic AMP levels in T lymphocytes transformed by human T-cell lymphotropic virus type 1.

Kress A, Schneider G, Pichler K, Kalmer M, Fleckenstein B, Grassmann R J Virol. 2010; 84(17):8732-42.

PMID: 20573814 PMC: 2918996. DOI: 10.1128/JVI.00487-10.


Upregulation of human T-cell leukemia virus type 1 antisense transcription by the viral tax protein.

Landry S, Halin M, Vargas A, Lemasson I, Mesnard J, Barbeau B J Virol. 2008; 83(4):2048-54.

PMID: 19073733 PMC: 2643783. DOI: 10.1128/JVI.01264-08.


T-cell receptor/CD28 engagement when combined with prostaglandin E2 treatment leads to potent activation of human T-cell leukemia virus type 1.

Dumais N, Pare M, Mercier S, Bounou S, Marriot S, Barbeau B J Virol. 2003; 77(20):11170-9.

PMID: 14512564 PMC: 224985. DOI: 10.1128/jvi.77.20.11170-11179.2003.


References
1.
Maca R . The effects of cyclic nucleotides on the proliferation of cultured human T-lymphocytes. Immunopharmacology. 1984; 8(2):53-60. DOI: 10.1016/0162-3109(84)90043-2. View

2.
Aussel C, Mary D, Peyron J, Pelassy C, Ferrua B, Fehlmann M . Inhibition and activation of interleukin 2 synthesis by direct modification of guanosine triphosphate-binding proteins. J Immunol. 1988; 140(1):215-20. View

3.
Fujisawa J, Seiki M, Kiyokawa T, Yoshida M . Functional activation of the long terminal repeat of human T-cell leukemia virus type I by a trans-acting factor. Proc Natl Acad Sci U S A. 1985; 82(8):2277-81. PMC: 397540. DOI: 10.1073/pnas.82.8.2277. View

4.
Rosen C, Sodroski J, Haseltine W . The location of cis-acting regulatory sequences in the human T cell lymphotropic virus type III (HTLV-III/LAV) long terminal repeat. Cell. 1985; 41(3):813-23. DOI: 10.1016/s0092-8674(85)80062-3. View

5.
Chen I, Slamon D, Rosenblatt J, Shah N, Quan S, Wachsman W . The x gene is essential for HTLV replication. Science. 1985; 229(4708):54-8. DOI: 10.1126/science.2990037. View